ABCB4 and Hepatic fibrosis: JD5037 treatment exacerbated liver injury in Mdr2−/− mice. To evaluate the effects of JD5037 on liver injury, we utilized 8-week-old Mdr2−/− mice, which spontaneously developed liver fibrosis.